Correlation Between Dyadic International and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and VistaGen Therapeutics, you can compare the effects of market volatilities on Dyadic International and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and VistaGen Therapeutics.
Diversification Opportunities for Dyadic International and VistaGen Therapeutics
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dyadic and VistaGen is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and VistaGen Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 2.25 times more return on investment than VistaGen Therapeutics. However, Dyadic International is 2.25 times more volatile than VistaGen Therapeutics. It trades about 0.1 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 123.00 in Dyadic International on September 16, 2024 and sell it today you would earn a total of 40.00 from holding Dyadic International or generate 32.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. VistaGen Therapeutics
Performance |
Timeline |
Dyadic International |
VistaGen Therapeutics |
Dyadic International and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and VistaGen Therapeutics
The main advantage of trading using opposite Dyadic International and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.Dyadic International vs. Puma Biotechnology | Dyadic International vs. Iovance Biotherapeutics | Dyadic International vs. Zentalis Pharmaceuticals Llc | Dyadic International vs. Syndax Pharmaceuticals |
VistaGen Therapeutics vs. Puma Biotechnology | VistaGen Therapeutics vs. Iovance Biotherapeutics | VistaGen Therapeutics vs. Zentalis Pharmaceuticals Llc | VistaGen Therapeutics vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |